• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

Life Sciences | News, Analysis, Insights - HIT Consultant

CVS Health Launches Clinical Trial Services Business for Investigational COVID-19 Vaccines & Treatments

by Fred Pennic 05/20/2021 Leave a Comment

CVS Health Launches Clinical Trial Services Business for Investigational COVID-19 Vaccines & Treatments

What You Should Know:  - Today, CVS Health announced the launch of a new Clinical Trial Services business, driving greater access to clinical trials across the communities CVS Health serves and creating a more efficient, convenient experience to improve participant retention and research effectiveness. - CVS Health collaborated with the pharmaceutical industry to help facilitate clinical trials for investigational COVID-19 vaccines and treatments. Using a specially designed
Read More

Cue Health Raises $235M to Scale Connected, Molecular Diagnostic System

by Fred Pennic 05/13/2021 Leave a Comment

Cue Health

 What You Should Know: - Cue Health Inc., a health technology company, today announced the closing of a $235 million private financing round. The investment includes participation from new investors Perceptive Advisors, MSD Capital, and Koch Strategic Platforms, a subsidiary of Koch Industries, existing investors Johnson & Johnson Innovation – JJDC, Inc. (JJDC), Decheng Capital, CAVU Ventures, ACME Capital, and others. - In March, the FDA granted Emergency Use Authorization for
Read More

Perceptive Advisors Closes $515M Early-Stage Biotech Fund

by Jasmine Pennic 05/13/2021 Leave a Comment

What You Should Know: - Perceptive Advisors and biotech accelerator Xontogeny, focused on seed investment, incubation and collaboration, have raised their second venture capital fund, the Perceptive Xontogeny Ventures Fund II (PXV Fund II), totaling an over-subscribed $515 million. This more than triples Assets Under Management to more than $700M in less than two years. - The
Read More

Axtria Secures $150M for AI-Enabled Platform for Life Sciences

by Fred Pennic 05/13/2021 Leave a Comment

Axtria Secures $150M for AI-Enabled Platform for Life Sciences

What You Should Know: -  Bain Capital Tech Opportunities has announced a $150 million growth investment in Axtria, a global cloud software and data analytics provider that helps life sciences businesses bring therapeutics to market faster – which will help Axtria to consolidate its strong position in cloud software and artificial intelligence by rapidly expanding its suite of life sciences-focused SaaS platforms. - With the life sciences and healthcare
Read More

CVS Health Expands Return Ready Vaccine Clinics to Accommodate Small Business & Schools

by Fred Pennic 05/12/2021 Leave a Comment

CVS Health Expands Return Ready Vaccine Clinics to Accommodate Small Business & Schools

What You Should Know: - Today, CVS Health announced that it will expand Return Ready, the company’s comprehensive COVID-19 solution that helps employers and schools return and maintain healthy communities, with scalable vaccine clinics to accommodate smaller workplaces/communities and schools given the Food and Drug Administration (FDA) emergency use authorization of the Pfizer-BioNTech vaccine for adolescents ages 12 to 15. - Small businesses and schools with more than
Read More

Florence Raises $80M to Expand Connectivity Platform for Clinical Trials

by Jasmine Pennic 05/06/2021 Leave a Comment

What You Should Know: - Florence, a site connectivity platform in clinical trials, today announced the close of a $80 million Series C funding round led by Insight Partners, a global venture capital and private equity firm focused on investing in ScaleUp software companies. Existing investors Fulcrum Equity Partners, Bee Partners, and Flashpoint also joined this round. - Based in Atlanta, GA, Florence is a global leader in remote connectivity and electronic document workflow management for
Read More

Cellares Secures $82M to Automate Cell Therapy Manufacturing

by Fred Pennic 05/06/2021 Leave a Comment

Cellares Secures $82M to Automate Cell Therapy Manufacturing


Read More

Cancer Centers: Here’s How We Can Restart Clinical Trials Today

by Marie E. Lamont, President and COO of Inteliquet 05/05/2021 Leave a Comment

Cancer Centers: Here’s How We Can Restart Clinical Trials Today

Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More

Walgreens Rolls Out Mobile Clinics to Bring COVID-19 Vaccines to Underserved Communities in Chicago

by Jasmine Pennic 05/04/2021 Leave a Comment

Walgreens Rolls Out Mobile Clinics to Bring COVID-19 Vaccines to Underserved Communities in Chicago

What You Should Know: - Walgreens will activate multiple mobile clinics in Chicago. The traveling mobile clinics will focus on bringing COVID-19 vaccines directly to underserved communities and those with barriers to accessing the vaccine. Over the next two months, additional mobile clinics will make stops in a number of locations across the country. - Individuals will be able to walk up to a mobile clinic and receive a vaccination at that time from a Walgreens pharmacy team member.
Read More

DoD, Duke, John Hopkins, HJF, physIQ Launch 18-Month COVID-19 Clinical Trial Study

by Jasmine Pennic 05/04/2021 Leave a Comment

COVID-19 Vaccine Cyber Attacks

What You Should Know: - Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More

  • Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 74
  • Go to page 75
  • Go to page 76
  • Go to page 77
  • Go to page 78
  • Interim pages omitted …
  • Go to page 92
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |